pharmaphorum
DECEMBER 1, 2021
The French group said that ORI-001, a vaccine based on recombinant proteins from the Cutibacterium acnes (formerly Propionibacterium acnes ) bacterium that is often found in acne lesions, could be the first ever vaccine for the condition.
Pharmaceutical Technology
JUNE 21, 2023
Based on these findings, GlobalData believes that the eradication of this bacterium by a non-hormonal antibiotic treatment may represent a promising approach to treating endometriosis for women who are positive for Fusobacteria infection, as well as for those women with endometriosis trying to conceive or who do not wish to use hormone treatments.
XTalks
AUGUST 2, 2023
5) Ibrance (palbociclib) Ibrance is a chemotherapy drug indicated for hormone receptor positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) metastatic breast cancer. It is a CDK 4/6 inhibitor that is taken in combination with other hormonal therapies to stop the growth of cancer and healthy cells. billion in 2022.
Expert insights. Personalized for you.
104 
Let's personalize your content